Heterogeneous SSTR2 target expression and a novel KIAA1549 :: BRAF fusion clone in a progressive metastatic lesion following ¹⁷⁷ Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report.

Autor: Park SWS; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Fransson S; Department of Laboratory Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Sundquist F; Department of Urology, Karolinska University Hospital, Stockholm, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Nilsson JN; Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Grybäck P; Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Wessman S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden., Strömgren J; Department of Pediatric Radiology, Karolinska University Hospital, Stockholm, Sweden., Djos A; Department of Laboratory Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Fagman H; Department of Laboratory Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Sjögren H; Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg, Sweden., Georgantzi K; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Pediatric Oncology, Karolinska University Hospital, Stockholm, Sweden., Herold N; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Pediatric Oncology, Karolinska University Hospital, Stockholm, Sweden., Kogner P; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Pediatric Oncology, Karolinska University Hospital, Stockholm, Sweden., Granberg D; Department of Breast, Endocrine Tumors and Sarcomas, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden., Gaze MN; Department of Oncology, University College London Hospitals National Health Service (NHS) Foundation Trust, London, United Kingdom., Martinsson T; Department of Laboratory Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Karlsson K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Stenman JJE; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Pediatric Surgery, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Sep 11; Vol. 14, pp. 1408729. Date of Electronic Publication: 2024 Sep 11 (Print Publication: 2024).